Embla Medical hf. Stock

Equities

EMBLA

IS0000000040

Medical Equipment, Supplies & Distribution

Delayed Nasdaq Copenhagen 04:45:17 2024-04-26 am EDT 5-day change 1st Jan Change
29.4 DKK +0.68% Intraday chart for Embla Medical hf. -4.55% +7.10%
Sales 2024 * 869M 6.04B Sales 2025 * 945M 6.57B Capitalization 1.79B 12.45B
Net income 2024 * 72M 501M Net income 2025 * 86M 598M EV / Sales 2024 * 2.53 x
Net Debt 2024 * 412M 2.86B Net Debt 2025 * 383M 2.66B EV / Sales 2025 * 2.3 x
P/E ratio 2024 *
23.7 x
P/E ratio 2025 *
19.9 x
Employees 3,999
Yield 2024 *
-
Yield 2025 *
-
Free-Float 48.4%
More Fundamentals * Assessed data
Dynamic Chart
1 day-5.19%
1 week-1.02%
Current month-12.84%
1 month-14.87%
3 months-0.85%
6 months+9.98%
Current year+6.38%
More quotes
1 week
29.20
Extreme 29.2
32.30
1 month
29.20
Extreme 29.2
34.00
Current year
26.50
Extreme 26.5
35.70
1 year
25.25
Extreme 25.25
35.70
3 years
25.25
Extreme 25.25
49.85
5 years
25.25
Extreme 25.25
57.80
10 years
12.00
Extreme 12
57.80
More quotes
Managers TitleAgeSince
Chief Executive Officer 46 08-12-31
Director of Finance/CFO 58 22-08-31
Chief Operating Officer - 23-06-14
Members of the board TitleAgeSince
Director/Board Member 73 13-02-28
Chairman 66 04-12-31
Director/Board Member 59 08-01-31
More insiders
Date Price Change Volume
24-04-26 29.4 +0.68% 1 877
24-04-25 29.2 -5.19% 13,134
24-04-24 30.8 +0.33% 76,638
24-04-23 30.7 +1.99% 68,158
24-04-22 30.1 -2.27% 3,436

Delayed Quote Nasdaq Copenhagen, April 25, 2024 at 10:59 am EDT

More quotes
Embla Medical hf, formerly Ossur hf, is an Iceland-based company that operates within the field of medical equipment and supplies sector. The Company is active in the development and distribution of products in the fields of non-invasive prosthetics, medical braces and supports. The Company's business activities are divided into three business segment: The Prosthetics, its product portfolio includes a range of lower and upper limb prosthetic components; The Bracing & Supports, which offers the Unloader One range of knee braces that relieve pain from knee osteoarthritis, as well as the Unloader Hip which is designed to reduce pain by optimizing load dispersion for patients suffering from mild and moderate osteoarthritis of the hip; and The Patient Care, which operates a network of Patient Care clinics around the world, with each one catering to individual patients and their needs.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
4
Last Close Price
29.2 DKK
Average target price
34.52 DKK
Spread / Average Target
+18.22%
Consensus